I will make a bold prediction... I still do think that $SPHS partners for their BPH drug by mid 2016, and trades above 5$ by that point. For that reason, I still continue to hold 220K shares. I also think that part of the reason $SPHS can't get no respect (Rodney Dangerfield-style) is that people think $NYMX is in the lead for FDA approval, but IMO there is no way they are.
I also think that THLD hits 1$ within 3-5 months, but time will tell. Long $THLD (0.58 ave) and $SPHS.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.